# Sichuan Deebio Pharmaceutical Co., Ltd. – FDA Inspection, Sep 8, 2023

Source: https://www.keypedia.com/records/fda_inspections/sichuan-deebio-pharmaceutical-co-ltd/9b3eed2e-55d7-4a5b-94fd-dc8fa40a96ae
Source feed: FDA_Inspections

> FDA inspection 1219423 of Sichuan Deebio Pharmaceutical Co., Ltd., September 08, 2023. Classification: Official Action Indicated (OAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219423
- Company Name: Sichuan Deebio Pharmaceutical Co., Ltd.
- Inspection Date: 2023-09-08
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Investigator](https://www.keypedia.com/people/anders-w-evenson/751222ba-2ec4-4594-aa4d-1e40b0e61063)
- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/sichuan-deebio-pharmaceutical-co-ltd/45f37698-bc0d-45b3-a46e-9243d9625e5c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
